Ticker Details
Tevogen Bio Holdings Inc. Common Stock
IPO Date:	February 15, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$40.24M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.14 | 5.83%
Avg Daily Range (30 D):	$0.57 | 7.30%
Avg Daily Range (90 D):	$0.32 | 5.86%

Institutional Daily Volume
Avg Daily Volume:	2.57M
Avg Daily Volume (30 D):	.02M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	368
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	392

Institutional Trades
Total Institutional Trades:	4
Avg Institutional Trade:	$.83M
Avg Institutional Trade (30 D):	$.98M
Avg Institutional Trade (90 D):	$.98M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.86M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	18.27K

News

May 21, 2026 @ 4:15 PM Tevogen Signs Letter of Intent to Evaluate Potenti... Source: Na

Mar 13, 2026 @ 6:45 PM Tevogen Reaffirms Capital Discipline as Lead Inves... Source: Na

Mar 11, 2026 @ 7:15 PM Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Comm... Source: Na

Mar 6, 2026 @ 5:42 PM Tevogen Bio Explores Buyout To Boost Generics Plat... Source: Vandana Singh

Mar 5, 2026 @ 7:50 PM Tevogen Advances Generics Strategy, Signs Letter o... Source: Globe Newswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.61	$-7.96	$-8.08
Diluted EPS	$-1.61	$-7.96	$-8.08
Revenue	$-.07M	$-.07M	$-.2M
Gross Profit
Net Income / Loss	$-5.45M	$-4.68M	$-26.28M
Operating Income / Loss	$-5.4M	$-4.61M	$-26.14M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Mar 06, 2026	1:50